Helicobacter pylori virulence factors and the host immune response: Implications for therapeutic vaccination

Trends in Microbiology

Volumn 11, Issue 3, 2003, Pages 134-138

  Prinz, Christian ^a   Hafsi, Nadia ^a   Voland, Petra ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL ANTIGEN; CAGA PROTEIN; UREASE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; CLINICAL TRIAL; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; VACCINATION;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 0037342772     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(03)00024-6     Document Type: Review

References (49)

1. Uemura N., et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:2001;784-789.
2. Sipponen P., et al. Pathogenesis of the transformation from gastritis to malignancy. Aliment. Pharmacol. Ther. 12:(Suppl. 1):1998;61-71.
3. Go M. Natural history and epidemiology of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 16:(Suppl. 1):2002;3-15.
4. Brown L.M. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 22:2000;283-297.
5. Mobley H.L., et al. Molecular biology of microbial ureases. Microbiol. Rev. 59:1995;451-480.
6. Smoot D.T., et al. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect. Immun. 58:1990;1992-1994.
7. Mobley H.L. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment. Pharmacol. Ther. 10:(Suppl. 1):1996;57-64.
8. +-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science. 287:2001;482-485.
9. Bury-Mone S., et al. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol. Microbiol. 42:2001;1021-1034.
10. Del Giudice G., et al. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 19:2001;523-563.
11. Michetti P., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 116:1999;804-812.
12. Ermak T.H., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:1998;2277-2288.
13. Smythies L.E., et al. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol. 165:2000;1022-1029.
14. Reyrat J.M., et al. Structural overview of the Helicobacter cytotoxin. Int. J. Med. Microbiol. 290:2000;375-379.
15. Covacci A., et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. U. S. A. 90:1993;5791-5795.
16. Censini S., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14648-14653.
17. Atherton J.C., et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 112:1997;92-99.
18. Gerhard M., et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc. Natl. Acad. Sci. U. S. A. 96:1999;12778-12783.
19. Haeberle H.A., et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect. Immun. 65:1997;4229-4235.
20. Ilver D., et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigen revealed by retagging. Science. 279:1998;373-377.
21. Prinz C., et al. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 61:2001;1903-1909.
22. Rad R., et al. The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J. Immunol. 168:2002;3033-3041.
23. Alm R.A., et al. Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect. Immun. 68:2000;4155-4168.
24. Keenan J., et al. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol. Lett. 182:2000;259-264.
25. Meyer F., et al. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun. 68:2000;6265-6272.
26. Blanchard T.G., et al. Host response and vaccine development to Helicobacter pylori infection. Curr. Top. Microbiol. Immunol. 241:1999;181-213.
27. Blaser M.J. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol. 1:1993;255-260.
28. Crabtree J.E., et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J. Clin. Pathol. 48:1995;41-45.
29. Crabtree J.E. Immune and inflammatory responses to Helicobacter pylori infection. Scand. J. Gastroenterol. (Suppl.). 215:1996;3-10.
30. Ramarao N., Meyer T.F. Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fluorescence-activated cell sorting. Infect. Immun. 69:2001;2604-2611.
31. D'Elios M.M., et al. T helper effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:1997;962-967.
32. + lymphocytes in Helicobacter gastritis display a Th1 phenotype. Infect. Immun. 66:1998;5543-5546.
33. Mohammadi M., et al. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:1996;4729-4738.
34. Wang J., et al. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J. Immunol. 167:2001;926-934.
35. Wagner H. Toll meets bacterial CpG-DNA. Immunity. 14:2001;499-502.
36. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:2002;709-760.
37. Ballas Z.K., et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J. Immunol. 167:2001;4878-4886.
38. + T cell responses and protection against Leishmania major infection. J. Exp. Med. 195:2002;1565-1573.
39. Kotloff K.L., et al. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69:2001;3581-3590.
40. DiPetrillo M.D., et al. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine. 18:1999;449-459.
41. Angelakopoulos H., Hohmann E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2000;2135-2141.
42. Bumann D., et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine. 20:2001;845-852.
43. Marchetti M., et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 267:1995;1655-1658.
44. Lee C.K., et al. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine. 17:1999;3072-3082.
45. Dubois A., et al. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect. Immun. 66:1998;4340-4346.
46. Marchetti M., et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine. 16:1998;33-37.
47. Lee C.K., et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine. 17:1999;1493-1505.
48. Guy B., et al. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice. Vaccine. 17:1999;1130-1135.
49. Ghiara P., et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect. Immun. 65:1997;4996-5002.